Literature DB >> 6461279

Antidiuretic and growth hormone responses during coronary artery surgery with sufentanil-oxygen and alfentanil-oxygen anesthesia in man.

S de Lange, M J Boscoe, T H Stanley, N de Bruijin, D M Philbin, C H Coggins.   

Abstract

Antidiuretic hormone (ADH), growth hormone (GH), and cardiovascular responses to large (anesthetic) doses of alfentanil (1.2 +/- 0.02 mg/kg) and oxygen and sufentanil (13.1 +/- 0.4 microgram/kg) and oxygen were measured before and during surgery (including cardiopulmonary bypass) and at the end of surgery in 29 patients undergoing coronary artery bypass surgery. The data demonstrate that alfentanil-O2 and sufentanil-O2 result in little change in cardiovascular dynamics throughout anesthesia and surgery, and also prevent changes in plasma levels of ADH and GH at all times during the study. Our findings contrast with previous studies with other anesthetics, including fentanyl, in which plasma levels of ADH and GH become markedly elevated during bypass. The results suggest that alfentanil and sufentanil may block hormonal stress responses to surgical stimulus better than fentanyl does. The clinical significance of the difference in ADH and GH responses during fentanyl and during alfentanil or sulfentanil anesthesia remains to be determined. However, this difference may provide part of the explanation why alfentanil and sufentanil-O2 anesthesia require less frequent employment of other anesthetic adjuvants and are easier to use than fentanyl during coronary artery surgery.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461279

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

Review 1.  Sufentanil. A review of its pharmacological properties and therapeutic use.

Authors:  J P Monk; R Beresford; A Ward
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

2.  Placement of the pulmonary arterial catheter before anesthesia for cardiac surgery: a stressful, painful, unnecessary crutch.

Authors:  R Dzelzkalns; T H Stanley
Journal:  J Clin Monit       Date:  1985-07

3.  Endocrine and hemodynamic changes during liver surgery in patients with compensated liver cirrhosis.

Authors:  K Maruyama; S Sakakura; K Nishimura; T Kurioka; R Horiguchi; M Muneyuki
Journal:  J Anesth       Date:  1993-04       Impact factor: 2.078

Review 4.  Clinical pharmacokinetics of the newer intravenous anaesthetic agents.

Authors:  P J Davis; D R Cook
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

5.  Catecholamine and cortisol responses to sufentanil-O2 and alfentanil-O2 anaesthesia during coronary artery surgery.

Authors:  S de Lange; T H Stanley; M J Boscoe; N de Bruijn; L Berman; O Green; D Robertson
Journal:  Can Anaesth Soc J       Date:  1983-05

6.  Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia.

Authors:  A J Boulton; N Wilson; K W Turnbull; R W Yip
Journal:  Can Anaesth Soc J       Date:  1986-07

7.  A comparative evaluation of intrathecal bupivacaine alone, sufentanil or butorphanol in combination with bupivacaine for endoscopic urological surgery.

Authors:  Manpreet Kaur; Sunil Katyal; Suneet Kathuria; Prabhjot Singh
Journal:  Saudi J Anaesth       Date:  2011-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.